A Study for Participants With Relapsed Cutaneous T-Cell Lymphoma

Clinical trial NCT00744991 · COMPLETED

Trial details

NCT number: NCT00744991
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Cutaneous T-Cell Lymphoma

Start date: 2008-09-01
Primary completion: 2010-01-01
Enrollment: 25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.